SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BIGFRED who wrote (1170)6/26/1998 9:29:00 AM
From: LFISKY   of 4650
 
Big Fred,
I am a little bit rusty on my accounting rules because I haven't done much public accounting lately, but I think this will help. Because ADOT currently owns between 20% and 50% of Biomoda, the key issue on whether they should treat their investment under the cost or equity method lies in their ability to exert significant influence over the control of Biomoda. (i.e. representation on board, participation in policy making, intercompany balances, technological dependency, etc.) Recently the profession has concluded that anything over 20%, without evidence to contrary would be enough to exert influence and therefore use the equity method. What this means is that ADOT would recognize their percentage of Biomoda's earnings. If not, they would use the cost method and only report any dividends that Biomoda would pay out.

Hope this helps,
LFISKY
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext